NLM logo
Search help
1,986 results
  1. Cabozantinib (Cabometyx) for the treatment of advanced hepatocellular carcinoma (liver cancer): Overview - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK541150
    ... Search term Cabozantinib (Cabometyx) for the treatment of advanced hepatocellular carcinoma (liver cancer): Overview Created: April 11, 2019 ; Next ... Germany since November 2018 for the treatment of advanced hepatocellular carcinoma in adults who have already had treatment with ...
  2. Pembrolizumab (Keytruda) for the treatment of advanced bladder cancer (urothelial carcinoma): Overview - InformedHealth.... 
    https://www.ncbi.nlm.nih.gov/books/NBK481481
    ... Search term Pembrolizumab (Keytruda) for the treatment of advanced bladder cancer (urothelial carcinoma): Overview Created: January 25, 2018 ; Last Update: April ...
  3. Laryngeal Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65746
    ... treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients ... treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients ...
  4. Table of Eligible Studies - Particle Beam Radiation Therapies for Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK44537
    ... et al. Helium charged-particle radiotherapy of locally advanced carcinoma of the esophagus, stomach, and biliary tract. American ... escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. International Journal of Radiation ...
  5. Systemic Therapy - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK82144
    ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for ...
  6. Prostate Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66036
    ... androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol ... 67, 1999. [ PubMed : 10071290 ] Millikan RE: Chemotherapy of advanced prostatic carcinoma. Semin Oncol 26 (2): 185-91, 1999. [ PubMed : ...
  7. MedlinePlus Drug Information: Axitinib 
    https://medlineplus.gov/druginfo/meds/a612017.html
    Axitinib is used alone to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in people who have not been treated successfully with ...
  8. Factors Influencing Management - Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK82139
    ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for ... II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for ...
  9. Antineoplastons (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65872
    ... H, Uchida M, et al.: Antineoplaston treatment for advanced hepatocellular carcinoma. Oncol Rep 5 (6): 1363-7, 1998 Nov- ... H, Uchida M, et al.: Antineoplaston treatment for advanced hepatocellular carcinoma. Oncol Rep 5 (6): 1363-7, 1998 Nov- ...
  10. Adult Primary Liver Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66030
    ... Ricci S, Mazzaferro V, et al.: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (4): 378-90, ... Ricci S, Mazzaferro V, et al.: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (4): 378-90, ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last